Home / About Us / Board of Directors

Board of Directors

Meet the Board

Board of Directors Board of Governors Emeritus Members

Meet the Biocom California Board of Directors, working to ensure Biocom California’s programs, initiatives, and strategies work to accelerate life science across California.

board-of-directors

Board of Directors

Sabrina Martucci Johnson

Chair; President and CEO

Daré Biosciences

Carin Canale-Theakston

Vice Chair, Professional Services

Inizio and Inizio Evoke

Ranjeet Banerjee

Vice Chair, DE&I; CEO

Cold Chain Technologies

Aliza Apple, Ph.D.

Vice President, Catalyze360 AI/ML

Eli Lilly

Matthew Bresnahan, J.D.

Partner

Wilson Sonsini

Dan Burgess

Chairman

Nabriva Therapeutics, PLC

Chuck Dadswell, J.D.

Advisor to CEO & Board of Directors

Illumina

Stephen Ferruolo, J.D., Ph.D.

Secretary, Professor

USD School of Law

Joydeep Ganguly

Sr. Vice President, Corporate Operations & Chief Sustainability Officer

Gilead Sciences

Jennifer Giottonini Cayer

Chief Business Officer

Pulmocide

Jeffrey Hessekiel

Executive Vice President & General Counsel

Exelixis, Inc.

Enoch Kariuki, PharmD

President

Endeavor Biomedicines

Dan Kleeburg

Treasurer; Partner

Ernst & Young LLP

Susan Krumplitsch

Partner

DLA Piper

Paul Mola

CEO

Armida Labs

Carolyn Ng, Ph.D.

Business Unit Partner

TPG Life Sciences Innovations

Bernard Parker

Chief Business Officer

SPHBio

Ken Rollins

Partner

Cooley

Christophe Schilling, Ph.D.

CEO

Genomatica, Inc.

Tim Scott

President and CEO

Biocom California

John Sos

SVP & Group President Life Sciences Solutions Group

Thermo Fisher Scientific

Nick Tait

Principal,

Marsh & McLennan Agency

Nancy Whiting, Pharm.D.

President and CEO

Recludix Pharma

“It’s so rewarding to see the tremendous impact the board has on advancing Biocom California’s key initiatives and, through that, invigorating the entire Southern California life science community.”

Carin Canale

CEO, Canale Communications

“As past Chairman and current Board member of Biocom California, I am thrilled that this organization continues to have such an impactful role in building the Life Science industry in California and in doing so contributes in a big way to the innovation economy. On a personal note, I treasure the time I spend on this dedicated Board with so many passionate and innovative leaders of this great industry.”

Magda Marquet

Co-Chairman & Founder, Althea

board-of-governors

Board of Governors

Matt Abernethy

CFO,

Neurocrine Biosciences

Connor Bates

Vice President/General Manager, Infusion Medication Management,

BD

Neil Bence, Ph.D.

VP, Head of Oncology Discovery,

Bristol Myers Squibb

Michael Boss

Sr. Vice President,

Alexandria Real Estate Equities

Thomas Briggs

Partner,

Jones Day

Mark Cafferty

President & CEO,

SD Regional Economic Development Corp.

Sunita Cooke, Ph.D.

Superintendent/President,

Mira Costa College

David Crean, Ph.D.

Managing General Partner,

Coast Bioventures LLC

Bassil Dahiyat, Ph.D.

President and CEO,

Xencor

DeeDee DeMan

Founder, Chairman & CEO,

Bench International

Thierry Diagana, Ph.D.

Head of Global Health & California Sites Head

Novartis Biomedical Research

Emad Fareed

Partner,

KPMG, Inc

Gregory Frost, Ph.D.

Chairman & CEO,

EXUMA Biotech

Ronnie Hanecak, Ph.D.

Senior Director, Licensing,

UCI Beall Applied Innovation

Stephen Hatke

Vice President of Operations & Thousand Oaks Site Head

Takeda

Richard Heyman, Ph.D.

Venture Partner

ARCH Ventures

Ted Jacobs

Vice Chairman,

CBRE

Cheston Larson, J.D.

Partner & Co-Chair, Life Sciences Industry Group,

Latham & Watkins LLP

Kathryn Lowell

Group Vice President, Global Government Affairs

BioMarin Pharmaceutical Inc.

James Mackay, Ph.D.

CEO,

Aristea Therapeutics

Hala Madanat, Ph.D.

Vice President for Research & Innovation,

SDSU

Trevor Martin, Ph.D.

Co-Founder & CEO,

Mammoth Biosciences

Damien McDevitt, Ph.D.

CEO,

Aspen Neuroscience

Juli Moran

San Diego Office Managing Partner & Managing Director,

Deloitte Consulting LLP

Marc Morley, J.D.

Member,

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo

Corinne Peek-Asa, Ph.D.

Vice Chancellor, Research,

UCSD

Bob Ramos, J.D.

Partner,

Procopio

Tina Self

Senior VP/Biologics Manufacturing Capability Cluster Leader & Berkeley Site Head

Bayer

Tsuneo Takahashi

President,

NF Corporation

Olivier Toury

Co-Founder & CEO,

Neuroservices-Alliance

Kevin Tremblay

Sr. Director, SD Market Leader,

Biomed Realty

David Webb, Ph.D.

CEO,

Rev-Therapeutics

emeritus-members

Emeritus Members

John Dunn

General Counsel

Calcimedica

Wain Fishburn

Chair,

Critical Path Institute

Lisa Haile

Partner & Global Life Science Sector Chair,

DLA Piper

David Hale

Chairman,

Hale BioPharma Ventures

Guy Iannuzzi

CEO,

Mentus

Paul Laikind, Ph.D.

Principal,

GVM BioBusiness

Jack Lief

Director,

CeleCor

Magda Marquet, Ph.D.

Co-Founder & Co-CEO,

ALMA Life Sciences, LLC

Joe Panetta

President Emeritus

Biocom California

Trindl Reeves

Chief Sales Officer,

Marsh & McLennan Agency

Larry Stambaugh

Chairman

Molecular Assemblies, Inc.